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When a primary anastomosis of the trachea is not feasible, extensive 
grafting is required. However, despite the use of omental wrapping for 
revascularization, long-segment tracheal gratis frequently do not maintain 
structural integrity because of insufficient blood supply. We examined the 
use of basic fibroblast growth factor for preservation of longlsegment 
tracheal autografts after orthotopic transplantation with omental wrapping 
in 23 dogs. All animals received orthotopic tracheal transplantation, with 
14-ring autografls that occupied a major part of the thoracic trachea, and 
omental wrapping. The 23 animals were classified randomly into six groups 
as follows: no treatment (group I, n = 3), topical administration of fibrin 
glue alone (group II, n = 4), fibrin glue enriched with 1 btg/cm 2 basic 
fibroblast growth factor (group III, n = 4), fibrin glue enriched with 5 
gg/cm 2 basic fibroblast growth factor (group 1V, n = 4), and fibrin glue 
enriched with 10 ILtg/cm 2 basic fibroblast growth factor (groups V and VI, 
each n = 4). The omentum that was used to wrap the autografts was fed by 
the right gastroepiploic artery in groups I to V and by both the right 
gastroepiploic artery and splenic artery in group VI. All autogratis in 
groups I and II showed dissolution. Ten of 12 autografts in groups III, V, 
and VI did not maintain long-term structural integrity. By contrast, all 
autografts in group IV showed long-term viability, as demonstrated by graft 
patency, epithelialization, cartilage morphology, and vascularity. We con- 
clude that treatment with fibrin glue enriched with 5 /.ig/cm 2 basic 
fibroblast growth factor in combination with omental wrapping may 
prolong the viability of longlsegment tracheal autografts. (J Thorac Car- 
diovasc Surg 1997;113:26-36) 
W hen a primary anastomosis  not feasible after an extensive resection of the trachea, it is 
preferable to interpose a substitute trachea than to 
perform a terminal tracheostomy in the anterior 
mediastinum to improve the patient's quality of 
life. ~ However, prosthetic or ectopic tissue grafts 
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have achieved only limited success because of failure 
to reepithelialize and remain patent. 2'3 By contrast, 
tracheal grafts with native pithelium can maintain a
patent airway and retain elasticity and incorpora- 
tion. Therefore transplantation f the trachea may, 
in the future, be the preferred method for recon- 
struction of extensive tracheal defects. 
However, tracheal allotransplantation has two 
major difficulties, rejection and revascularization f 
the devascularized tracheal graft. We previously 
reported that epithelial morphology is valuable in 
the diagnosis of rejection and reported the efficacy 
of short-course immunosuppression. 4'5 We then 
studied the minimal dose of cyclosporine A in 
tracheal allotransplantation. 6 We also showed that 
omental wrapping is an effective method to facilitate 
neovascularization in tracheal autografts. 7 However, 
the omental blood supply could not maintain the 
viability of tracheal autografts longer than 4 cm in 
dogs because of the development of ischemia in the 
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middle part of the grafts. There is a limit to the 
length of viable tracheal autografts, even if the 
blood supply is potentiated by omental wrapping, s 
Because the ultimate objective of tracheal trans- 
plantation is extensive reconstruction, additional 
study is required to overcome this limitation of 
tracheal grafting. 
Viability of longer tracheal autografts requires 
enhancement of blood supply. Because basic fibro- 
blast growth factor (bFGF) is one of the most potent 
promoters of angiogenesis, we chose to investigate 
its ability to enhance blood supply to these grafts. 9
This study was undertaken to determine the optimal 
dose of bFGF  for long-segment tracheal autografts 
after orthotopic transplantation with omental wrap- 
ping in 23 dogs. We used autografts to avoid the 
immunologic omplexity of allografts in this exper- 
imental design. 
Material and methods 
Animals and anesthesia. Twenty-three adult male 
mongrel dogs weighing from 8.0 to 14.0 kg were premed- 
icated with an intramuscular injection of ketamine hydro- 
chloride (20 mg/kg). They were then placed in the supine 
position and anesthetized with an intravenous injection of 
pentobarbital sodium (10 mg/kg). Next, they were intu- 
bated orally and connected to a pressure-cycled respira- 
tor. Ventilation was done at a tidal volume of 30 ml/kg and 
a frequency of 15 breaths/min. Anesthesia was maintained 
with 50% oxygen, 50% nitrous oxide, and 1% halothane. 
All animals received humane care in compliance with the 
"Principles of Laboratory Animal Care" formulated by 
the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the National Academy of Scienees and pub- 
lished by the National Institutes of Health (NIH Publica- 
tion No. 86-23, revised 1985). 
Surgical teehnique. The animals were positioned for 
simultaneous right thoracotomy in the third intercostal 
space and upper midline laparotomy. After laparotomy, 
an omental pedicle was formed without splenectomy. 1° A 
standard posterolateral thoracotomy was then done. The 
intrathoracic trachea was exposed with sharp dissection, 
and a 14-ring segment of the traehea was identified, three 
rings above the carina, and removed. A 14-ring segment of 
the trachea represents almost the entire intrathoracic 
tracheal length in most dogs. The azygos and brachioce- 
phalic veins were preserved. These 14-ring autografts 
were then placed in physiologic saline solution at 10 ° to 
15 ° C for several minutes. A spiral endotracheal tube was 
positioned in the lower trachea for ventilation after resec- 
tion. The excised segment was then reimplanted in its 
original position as an autograft. The upper anastomosis 
was done frst with running 3-0 Prolene polypropylene 
sutures (Ethicon, Inc., Somerville, N.J.). Next, the mem- 
branous portion and two thirds of the cartilaginous por- 
tion of the lower anastomosis were sutured similarly. The 
spiral endotracheal tube was then removed from the 
Table I. Experimental design 
Fibrin Feeding artery 
glue bFGF of omental 
Groups n (1 ml) * (txg/cm 2)* flap 
I 3 - -  - -  rGEA 
II 4 + - -  rGEA 
III 4 + 1 rGEA 
IV 4 + 5 rGEA 
V 4 + 10 rGEA 
VI  4 + 10 rGEA + SA 
rGEA, Right gastroepiploic artery; SA, splenic artery. 
*All doses were administered topically during operation. 
operative field and ventilation was continued via the oral 
endotracheal tube. The lower anastomosis was subse- 
quently completed. 
Groups and drug administration. The 23 study animals 
were classified randomly into six treatment groups as 
follows: no treatment (group I, n = 3); topical adminis- 
tration of 2 ml of fibrin glue (Beriplast P, Behring Werke 
AG, Marburg, Germany; 1 ml fibrinogen/aprotinin, 1 ml 
thrombin/calcium chloride) (group II, n = 4); topical 
administration of fibrin glue mked with 1 / xg /cm 2 bFGF 
(KCB-1, 1 mg/ml, Kaken Pharma Inc., Chiba, Japan) 
(group III, n = 4); topical administration of fibrin glue 
mixed with 5/,g/cm 2bFGF (group IV, n = 4); and topical 
administration of fibrin glue mixed with 10/,g/em 2 bFGF 
(groups V and VI, each n = 4) (Table I). The dose of 
bFGF was calculated as a proportion of the surface area 
of the autograft, which was derived from the following 
formula: surface area of autograft = (a + b)/2 × rr × c, 
where a is the transverse diameter of a cross section of the 
oral end of the graft, b is the sagittal diameter of the same 
cross section, and c is the full length of the 14-ring of the 
graft. One milliliter of thrombin/calcium chloride (Beri- 
plast P) was mixed with the bFGF. This mixed solution 
and 1 ml of fibrinogen/aprotinin (Beriplast P) were simul- 
taneously administered to the graft. The outer surface of 
these autografts, including the anastomoses, was soaked 
circumferentially with the drugs after tracheal autotrans- 
plantation. 
Omental wrapping. All anirnals underwent omental 
wrapping after topical treatment of the autograft. We 
evaluated the viability of the omental flap that was formed 
at the beginning of this operation after tracheal autotrans- 
plantation. As a result, all the omental flaps maintained 
viability by means of having a rich blood flow. The 
omentum used to wrap the autografts was red by the right 
gastroepiploic artery in groups I to V and by both the right 
gastroepiploic artery and splenic artery in group VI. The 
omental pedicle was brought up via a diaphragmatic 
defect into the right thoracic avity. This pedMe was used 
to wrap the autograft circumferentially, including each 
end. The chest and abdominal incisions were then closed 
in standard fashion. The total operating time was approx- 
imately 11/2 hours. 
Postoperative management. Animals received antibiot- 
ics for the first 7 postoperative days. Bronchoscopic 
examinations were done weekly after the operation. 
2 8 Nakanishi et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
January 1997 
Fig. 1. Bronchoscopic findings in canine tracheal autograft on postoperative day 370 in group IV (dog No. 
14). A, Anastomotic site at oral end; B, midportion of graft; C, anastomotic site at caudal end. Graft was 
covered with glossy mucosa and showed good patency. 
Assessment of grafts 
Patency. The patency of the tracheal graft was assessed 
by calculating the percent patency after the animal had 
died or at the last bronchoscopic examination while the 
animal was alive. The percent graft patency was expressed 
as a proportion of the cross-sectional rea of the most 
stenotic site in the graft to the third tracheal ring above 
the upper anastomosis in the recipient trachea. The 
cross-sectional rea (CSA) was calculated from the fol- 
lowing formula: CSA = a/2 x b/2 x er, where a is the 
transverse diameter and b is the sagittal diameter, s 
Histologic assessment. All tissues were fixed in 10% 
formalin solution. Microscope slides were made from 
longitudinal sections of the trachea and adherent omen- 
turn and stained routinely with hematoxylin-eosin stain. 
Thereafter, all specimens were examined by light micros- 
copy. We attempted to quantify the viability of the 
orthotopic grafted trachea by subjectively evaluating the 
epithelial morphology and objectively counting the num- 
ber of vessels. The morphology of the cartilaginous rings 
was also assessed inasmuch as this has been reported to be 
closely associated with effects of bFGF. TM 12 These assess- 
ments were done in a blinded fashion. 
EPITHELIAL REGENERATION. Epithelial regeneration was 
evaluated according to the following grading system: 0, no 
epithelium; 1, single-layer nonciliated epithelium; 2, mul- 
tilayer nonciliated epithelium; and 3, normal mucociliary 
epithelium, s The epithelium of the grafts was assessed as 
a ratio of the epithelial regeneration score on a micro- 
scope slide. 
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Table Il. Survival and grafl status 
Graft status 
Groups Dog No. Survival (days) Cause of death (at time of death) 
I (control) Airway stenosls 
Airway stenos~s 
Airway stenosls 
Airway stenosls 
Airway stenosls 
Airway stenosas 
Airway stenosas 
Airway stenos~s 
Airway stenos~s 
Killed 
Källed 
IV (FG + bFGF 5/xg/cm 2) Killed 
Killed 
Killed 
Alive 
V (FG + bFGF 10 txg/cm 2) Infection 
Airway stenosis 
Airway stenosis 
Killed 
VI (FG + bFGF 10 pùg/cm2)t General marasmus 
General marasmus 
General marasmus 
Airway stenosis 
II (FG alone) 
III (FG + bFGF 1/xg/cm 2) 
1 9 
2 11 
3 12 
4 6 
5 9 
6 9 
7 11 
8 10 
9 15 
10 21 
11 215 
12 34 
13 169 
14 393 
15 673 
16 10 
17 33 
18 46 
19 375 
20 7 
21 20 
22 70 
23 87 
Dissolution 
Dissolution 
Dissolution 
Dissolution 
Dissolution 
Dissolution 
Dissolution 
Malacia 
Dissolution 
Large granulation 
'Weil healed 
Almost healed 
'Weil healed 
'Weil healed 
'Weil healed* 
Ischemic 
Severe malacia 
Severe malacia 
Malacia and granulation 
Malacia 
Malacia 
Almost healed 
Severe malacia 
FG, Fibrin glue. 
*Graft status of dog No. 15 was evaluated atmost recent bronchoscopic examination. 
J'In group VI, an omental flap was red by blood supplies from both the right gastroepiploic and splenic arteries. In other groups, this flap was red by the right 
gastroepiploic artery alone. 
CARTILAGE MORPHOLOGY. The morphology of the car- 
tilaginous rings was graded semiquantitatively from 0 to 3, 
with 0 indicating severe damage (necrosis area >70% of a 
microscopically visual field); l, moderate damage (between 
30% and 70% necrosis area); 2, mild damage (necrosis area 
<30%); and 3, no damage (normal cartilage). 
VESSEL NUMBEm The number of vessels in the submu- 
cosa of each graft was counted per high-powered field on 
a microscope slide. We examined longitudinal sections of 
the grafts to include both the middle part of the graft and 
the site of anastomosis, because there is a potential 
difference in blood flow between these sites. 8 No attempt 
was made to distinguish between arteries and veins. The 
data are presented as the average of three measurements 
for each graft. 
Statistieal methods. The probability of survival was cal- 
culated by the Kaplan-Meier method. 13 The significance of 
the differences in survival rates was computed by the log- 
rank testJ a All data as to patency, epithelial regeneration 
score, cartilage score, and vessel number of the graffs are 
presented as the mean and standard error. Statistical analysis 
was done by the paired Student's t test. Ap  value less than 
0.05 was considered statistically significant. 
Results 
Bronchoscopic findings. Tracheal autografts that 
did not receive bFGF (groups I and II) showed 
dissolution or disintegration of cartilage in the mid- 
portion of the graft as early as postoperative day 7, 
whereas almost all the autografts that received 
bFGF in doses greater than 5/xg/cm 2(groups IV to 
VI) maintained the baseline postoperative luminal 
structure to that time. Two of four grafts in group III 
showed disintegrations imilar to those in groups I 
and II 7 days after operation. All the autografts in 
group IV and one in group III (dog No. 11) showed 
gradual decreases in inflammation and demon- 
strated good patency and intact mucosa after the 
third postoperative week (Fig. 1). By contrast, in- 
flammation, stenosis, and mucosal changes in the 
remainder of autografts in group III and in all those 
in groups V and VI gradually worsened and the 
grafts eventually showed malacia. 
Survival (Table II). All animals in groups I and 
II, which did not receive bFGF, died of airway 
stenosis from graft dissolution within 2 weeks after 
operation. Although we had hoped that all animals 
that received bFGF would survive for a long period, 
almost all animals, except for those in group IV, 
died within 3 months after operation. By contrast, 
all animals in group IV survived for longer periods 
and were killed at various times for the purpose of 
assessing raft viability chronologically. The cumu- 
lative percent survival in groups I and II and in 
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Fig. 2. Cumulative percent survival. Survival in group IV differed significantly from survival in other 
groups (group IV versus groups I and II, p = 0.0080; group IV versus groups III, V, and VI, p = 0.0286). 
Survival in groups III, V, and VI differed significantly from survival in groups I and II (p = 0.0055). Mean 
survival time of each group was as follows: groups I and II, 9 days; groups III, V, and VI, 33 days. Mean 
survival time for group IV was not measured because animals were killed. 
groups III, V, and VI was significantly less than that 
in group IV (Fig. 2). 
Graf t  s ta tus  and  pereent patency (Table Il). 
When we harvested the grafts, the viable omentum 
was wrapped firmly around the tracheal autografts 
in all groups. All the autografts in groups I and Il 
showed dissolution (Fig. 3). The airway was nar- 
rowly maintained with connective tissue composed 
of omentum, although the percent patency of the 
airway was poor because of loss of luminal rigidity. 
In groups III, V, and VI (which received bFGF), 
stenosis of the autograft was seen in nine animals 
(75.0%) (3 animals from each group). In group III, 
stenosis of the autografts was caused by malacia, 
dissolution, or extensive granulation, whereas al- 
most all autografts in groups V and VI showed 
stenosis caused by malacia. By contrast, all the 
autografts in group IV had normal-appearing 
mucosa and good patency, and almost all were 
healed (Fig. 4). The graft patencies at each observed 
time in groups I and II were significantly worse 
than those 7 days after transplantation. A milder 
progressive loss of graft patency across these times 
was also seen in groups III, V, and VI. However, 
there was no difference in patency at any point in 
group IV. The average graft patency at all points 
was significantly better in group IV than in group I 
or II (Fig. 5). 
His to logy  
Epithelial regeneration. All animals in groups I 
and II and three animals in group III showed no 
epithelial regeneration i  the autografts. By con- 
trast, one autograft in group III and all those in 
group IV demonstrated normal mucociliary epithe- 
lium. Two animals in group V and three in group VI 
showed some reepithelialization f the autografts. 
These autografts howed partial restoration of the 
epithelium, which was almost covered by a single 
layer of nonciliated epithelium. The epithelial re- 
generation score of the grafts in group IV was 
significantly better than those in the other groups 
(Table III). 
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Fig. 3. Canine tracheal autograft on postoperative day 12 in group I (dog No. 3). A, Gross findings; B, 
histologic findings (hematoxylin-eosin stain; original magnification ×12.5). Autograft is necrotic and 
cartilage is disintegrated or dissolved. Epithelial regeneration is not seen. 
Cartilage morphology. In groups I and II, the 
cartilage of the autografts was either necrotic or 
absent. Three of four autografts in group III showed 
the same findings as those in groups I and II. The 
cartilage of the autograft in one animal of group III 
(dog No. 11) maintained its structural integrity. The 
autografts in group IV not only demonstrated via- 
bility but also showed areas of proliferation. In the 
autografts of groups V and VI, hyperplasia of the 
perichondrium and proliferation of cartilage was 
often seen on the adventitial side of the grafts. The 
cartilage score of grafts in groups IV and VI was 
significantly better than that of group I or II (Table 
III). 
Vessel number. In groups I and II, the autografts 
were so necrotic that few vessels were seen. Three 
autografts in group III had a few vessels. By con- 
trast, one autograft in group III and all those in 
group IV demonstrated many vessels and an intact 
interstitium. All the autografts in groups V and VI 
had some interstitial damage as evidenced by pro- 
liferation of granulation tissue, fibrosis, and hemor- 
rhage. Consequently, these autografts howed few 
intact vessels. Autografts in group IV demonstrated 
significantly higher numbers of vessels than those in 
all other groups, except for group VI (Fig. 6). 
Discussion 
Omentum is capable of revascularizing ischemic 
tissues and maintaining their viability without an 
apparent arterial blood supply, perhaps bccause the 
lipid fraction of omentum has specific angiogenic 
factors. 1» Omental wrapping has been proved to 
allow successful airway revascularization and im- 
prove bronchial healing in canine lung transplanta- 
tion models. 16 In clinical lung transplantation, how- 
ever, ischemic airway complications remain despite 
the use of omental wrapping, lv Omentum may, 
therefore, have a limited ability to revascularize. We 
previously demonstrated an inadequate blood sup- 
ply from the omentum to tracheal transplants. 8 
Dcvascularized tracheal transplants require en- 
hancement of the omental revascularization for 
prolonged graft survival. 
A few investigators have recently reported suc- 
cessful long-segment tracheal reconstruction with 
use of a composite thyrotracheal transplant, is This 
approach includes a technique for microvascular 
anastomoses to prcserve peritracheal mi¢rocircula- 
tion and can maintain its natural hemodynamics. 
Therefore these long-segment tracheal transplants 
can remain viable without further nhancement of
local vascularization. However, this approach is so 
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Fig. 4. Canine tracheal autograft on postoperative day 393 in group IV (dog No. 14). A, Gross findings; 
B, histologic findings (hematoxylin and eosin stain; original magnification × 12.5); C, epithelial morphology 
(original magnification x 100). Tracheal continuity is restored by autograft. Many vessels and proliferation 
of submucosal connective tissue and cartilage are seen, but narrowing of graft is not seen. Epithelium is 
almost completely restored (89.1%) and is composed of nearly normal mucociliary epithelium (epithelial 
regeneration score = 2.24). 
technically demanding that it may not be routinely 
available. 
In a medical approach to this problem, Inui and 
associates 19 have demonstrated that prostacyclin 
improves the microcirculation of bronchi after lung 
transplantation. This agent is a natural prostaglan- 
din with a strong vasodilatory action. Therefore 
systemic administration of this agent results in im- 
provement of bronchial blood flow and may reduce 
the incidence of bronchial complications after lung 
transplantation. However, administration to either 
the donor or recipient alone did not lead to such 
favorable results. Although the effects of this agent 
are encouraging, prostacyclin treatment alone is 
unlikely to achieve long-term survival of devascular- 
ized trachea. 
Recently a new approach that uses promotion of 
angiogenesis tself has been reported. Several vas- 
cular growth factors have been isolated and shown 
to induce angiogenesis. The most well described of 
these, bFGF, is a protein of approximately 17,000 
Da molecular weight and has been isolated from 
bovine pituitary tissue. 2° It is a potent angiogenic 
factor in vitro 9 and in vivo TM 22 and is mitogenic and 
chemotactic for both fibroblasts and endothelial 
cells. 23 This factor, which stimulates new blood 
vessel growth and fibroblast proliferation, leads to 
the formation of granulation tissue and is associated 
with reepithelialization. 24 Moreover, bFGF applied 
to freshly injured cartilage promotes cartilage re- 
pair. 12 We used bFGF in these experiments because 
it both enhances local revascularization and has 
positive effects on epithelium and cartilage, which 
are important components of tracheal transplants. 
There have been only three prior studies on 
tracheal revascularization with bFGF. The role of 
bFGF in revascularization of rabbit tracheal au- 
tografts was first reported by Olech and associates z5 
in 1991. They applied bFGF in a dose of 10 ng to 
rabbit tracheal autografts without any notable el- 
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Fig. 5. Average graft patency. Data are presented as mean plus or minus standard error. *, **, p < 0.05 
versus group I at that time; #, ##,  p < 0.05 versus group Il at that point (graft patency 7 days after 
transplantation: groups I versus IV, p = 0.0009; I versus VI, p = 0.0177; II versus IV, p = 0.0009; II versus 
VI, p = 0.0305, and graft patency at observed end-point: groups I versus IV, p = 0.0055; I versus VI, p = 
0.0124; II versus IV, p = 0.0004). Autografts in group IV showed good patency throughout entire 
postoperative course and were significantly superior to those in groups I and II, which did not receive 
bFGF. FG, Fibrin glue; rGEA, wrapping of omental flap red by right gastroepiploic artery; rGEA + SA, 
omental wrapping fed by blood supplies from both right gastroepiploic and splenic arteries. Open bars 
represent graft patency 7 days after transplantation; soIid bars represent patency at observed end-point. 
Table I I I .  Semiquantitative score of grafi histopathologic findings 
Groups Epithelial regeneration score Cartilage score 
I (control) 0 0 
II (FG alone) 0 0 
III (FG + bFGF 1/xg/cm 2) 0.56 _+ 0.56 0.75 _+ 0.75 
IV (FG + bFGF 5/xg/cm 2) 2.08 +_ 0.45"t 2.75 _+ 0.25"t 
V (FG + bFGF 10/xg/cm 2) 0.19 -+ 0.16 1.75 _+ 0.48t 
VI (FG + bFGF 10/xg/cm2):) 0.18 _+ 0.07 1.75 + 0.25"t 
Data are presented as mean plus or minus standard error of the mean. FG, Fibrin glue. 
*p < 0.05 versus group I. 
?p < 0.05 versus group II (epithelial regeneration score: groups I versus IV, p = 0.0431; I I  versus IV, p = 0.0431; cartilage score: groups I versus IV, p = 
0.0153; I versus VI, p = 0.0377; I I  versus IV, p = 0.0016; n versus V, p = 0.0354, I1 versus VI, p = 0.0000). 
~.Group VI  received an omental wrapping red by blood supplies from both the right gastroepiploic and splenic arteries in contrast o other groups in which 
this flap was fed by the right gastroepiploic artery alone. 
fects. On the other hand, Mayer and colleagues 20 
demonstrated that a 400 ng dose of bFGF  could 
promote the viability of heterotopic rat tracheal 
isografts. Albes and associates 27 showed that 2.5/xg 
bFGF improved revascularization of heterotopic 
rabbit tracheal autografts. Although these studies 
are not clinically applicable because of the use of a 
heterotopic transplantation model, they suggest hat 
adequate doses of bFGF  may prolong graft survival. 
Research on the dose effect of bFGF  has been 
3 4 Nakanishi et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
January 1997 
Vessel number * 
# 
1200 
800 
400 
| | 
Group I Group II Group III Group IV Group V Group VI 
Control FG alone 1/1 g/cm 2 5/z g/cm 2 10/1 g/cm 2 10 p g/cm 2 
[ FG + b-FGF I 
[ rGEA I rGEA+ SA 
Fig. 6. Number of blood vessels in tracheal gratis. Data are presented as mean plus or minus standard 
error. *,p < 0.05 versus group I; #,p < 0.05 versus group Il (groups I versus IV, p = 0.0141; I versus V, 
p = 0.0210; I versus VI, p = 0.0011; II versus IV, p = 0.0141; II versus V, p = 0.0433; II versus VI, p = 
0.0006). Autografts in group IV showed highest number of vessels and were significantly superior to those 
in all groups except for group VI. Vessel numbers of groups V and VI differed significantly from those of 
other three groups, except for group IV, but did not differ significantly from each other. FG, Fibrin glue; 
rGEA, wrapping of omental f ap fed by right gastroepiploic artery; rGEA + SA, omental wrapping fed by 
blood supplies from both right gastroepiploic and splenic arteries. 
evaluated in other organs. In a bone fracture model 
of rats, Kawaguchi and colleagues 2 demonstrated 
that treatment with bFGF caused a dose-dependent 
acceleration of callus formation. Application of 50 
Bg bFGF to the impaired fibula significantly in- 
creased the volume and mineral content of the 
callus when compared with application of less than 
10/.%28 That study gives the impression that higher 
doses of bFGF have more favorable effects. How- 
ever, it is possible that high-dose bFGF may also 
promote negative effects such as proliferation of 
granulation at the anastomotic site of the trachea. 
Therefore it is important o determine the optimal 
dose of bFGF required to promote revascularization 
after tracheal operation. We adopted an orthotopic 
canine tracheal transplantation model, close to the 
clinical setting, for the purpose of searching for this 
optimal dose in human beings. Although there was 
great variation in the doses of bFGF given to the 
various species of animals in the previously de- 
scribed three reports, we considered that the dose of 
bFGF should be determined as a proportion of 
surface area of the tracheal grafts. Klingbeil, Cesar, 
and Fiddes z9 assessed an adequate dose of bFGF 
similarly, on the basis of wound surface area in a 
diabetic mouse model. The low doses (0.01 and 0.1 
/xg/cm 2) did not accelerate wound healing but both 
1 and 10 /xg/cm 2 doses produced rapid wound 
closure. 29 We, therefore, chose the doses of bFGF 
from 1 to 10/xg/cm 2.
The mode of administration of bFGF is also 
problematic. It is important o retain bFGF at the 
surface of the organ for neovascularization. 21-24 
Thompson and colleagues 21 induced angiogenesis 
by means of direct implantation of Gelfoam sponges 
(The Upjohn Co. of Canada, Don Mills, Ontario, 
Canada) treated with acidic fibroblast growth factor 
at the surface of the neck or peritoneum. However, 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 113, Number 1 
Nakanishi et al. 3 5 
Olech and associates 2 failed to increase omental 
revascularization of tracheal transplants although 
the same Gelfoam product or Surgicel (Johnson & 
Johnson Products Inc., New Brunswick, N.J.) was 
used as a reservoir to provide the trachea with 
long-term exposure to bFGF. Both limited applica- 
tion time and inadequate dosage may decrease the 
effects of bFGF on tracheal transplants. Mayer and 
colleagues 26used a pump to provide a continuous 
supply of bFGF with favorable results. However, 
their approach is so clinically difficult that it may 
not be routinely accepted. Albes and associates 27
obtained success by use of a deposit of bFGF in 
fibrin glue. Their approach is a clinically practical 
mode and leads to prolonged exposure time of the 
grafts to bFGF because fibrin glue gradually re- 
leases this agent. Fibrin glue itself also can en- 
hance angiogenesis. 3° We therefore used this ap- 
plication mode. 
We designed this experimental model of tracheal 
autotransplantation f r the purpose of determining 
the angiogenic potential of bFGF. The statistical 
analysis in this study may show trends alone because 
the number of animals in each group was inade- 
quate for true significance to be demonstrated. Our 
results how that neither omentum alone nor omen- 
tum in combination with fibrin glue resulted in 
maintenance of the viability of long-segment tra- 
cheal autografts. These results supported our previ- 
ous findings that only short-segment autografts 
maintain viability after revascularization with omen- 
tal flaps. 7' s Fibrin glue did not enhance local revas- 
cularization of these 14-ring tracheal grafts. By 
contrast, all autografts that received the topical 
administration of 5 bog/cm 2 bFGF showed good 
viability over a long period, as demonstrated by 
gross and histologic findings. Treatment with 5 
Bg/cm 2 bFGF may enhance vascular ingrowth from 
the omentum in the early posttransplant period and 
subsequently decrease ischemia in the middle part 
of the grafts, s We believe that the optimal dose of 
bFGF for these tracheal grafts is probably 5/xg/cm 2. 
Doses of i /xg/cm 2may be too low to maintain the 
viability of long-segment tracheal grafts in light of 
our histologic findings, especially vessel number. 
Likewise, neither a bFGF dose of 10 p~g/cm 2 alone 
nor the same dose in combination with increased 
anatomic blood supply increased the vessel num- 
ber of the grafts or maintained the structural 
integrity of the grafts when compared with a dose 
of 5 /xg/cm 2. In view of the interstitial histologic 
findings of proliferation of granulation tissue and 
fibrosis, at a dose of 10 ~g/cm 2the negative ffects 
of bFGF may outweigh its benefits. Moreover, the 
unusual pattern of unilateral proliferation of car- 
tilage may be associated with tracheal malacia. 
Autografts treated with 10 /xg/cm 2 bFGF unex- 
pectedly showed poor reepithelialization. The 
proliferation of granulation tissue seen at this 
dose of bFGF may impair reepithelialization. The 
observed correlation between epithelialization 
and vascularity may suggest hat the acceleration 
of epithelial regeneration is caused by a revascu- 
larizing effect rather than a mitogenic effect of 
bFGF. 24-26 In our preliminary study, almost all 
the epithelium was lost after devascularization. The 
remaining degenerated epithelium was chronologi- 
cally restored to the normal respiratory epithelium 
after revascularization. 7 The epithelial morphology 
is closely associated with vascularization. 
We did not investigate very early revasculariza- 
tion after treatment with bFGF because the effects 
of bFGF on revascularization have been reported to 
occur only 7 to 14 days after its administration. 22'26 
The long-term effect of bFGF on graft viability is 
more important than its short-term effect. We have 
demonstrated that long-segment tracheal autografts 
treated with 5 /xg/cm 2 bFGF can maintain their 
long-term viability. Our results suggest hat bFGF 
may be useful in clinical trials for extensive tracheal 
reconstruction by transplantation. Additional study 
is required to evaluate the effect of bFGF on 
tracheal allografts in immunosuppressed hosts. We 
are now studying wound healing of the airway with 
the use of bFGF alone without omental wrapping 
and have obtained favorable results. 
We conclude that treatment with fibrin glue en- 
riched with 5 /xg/cm 2 bFGF in combination with 
omental wrapping may allow long-term viability of 
14-ring tracheal autografts that the omentum alone 
could not maintain. 
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